Skip to main content
. 2021 Feb 26;2021:6692544. doi: 10.1155/2021/6692544

Figure 4.

Figure 4

miR-145-5p functions on the proliferation, migration, and invasion of EC cells via targeting the expression of ABRACL. Control, miR-145-5p inhibitor, and miR-145-5p inhibitor+si-ABRACL were transfected into Eca-109 cells. (a) CCK-8 assay and (b) migration and (c) invasion assays (Transwell (100x)) show cell proliferative, migratory, and invasive abilities in each treatment group. ∗ indicates p < 0.05 relative to the control group; # indicates p < 0.05 relative to the miR-145-5p inhibitor group.